Fadi Saab

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Anahita Dua, MD, MS, MBA, FACS, is a vascular surgeon at Massachusetts General Hospital and an associate professor of Surgery at Harvard Medical School. At Mass General, she is the co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program (LEAPP), associate director of the Wound Care Center, clinical director of research, and associate director of the Vascular Surgery Clerkship.

She specializes in advanced endovascular (minimally invasive) and traditional (open) limb salvage techniques for treating peripheral arterial disease and critical limb ischemia, diabetic limb disease, aortic disease, carotid disease, thoracic outlet syndrome and venous disease.

Dr. Dua completed her vascular surgery fellowship at Stanford University Hospital and general surgery residency at the Medical College of Wisconsin. She has also completed a master’s degree in trauma sciences, a master’s in business administration in health care management and has a certificate in health economics/outcomes research as well as a certificate in drug and device development from the Massachusetts Institute of Technology. She is board-certified in vascular surgery, general surgery and advanced wound care and management.

Dr. Dua has published over 200 peer reviewed papers and has edited four vascular surgery medical textbooks. She serves on multiple national vascular surgery committees through the Society for Vascular Surgery and other vascular organizations including the South Asian-American Vascular Society and American College of Surgeons. Dr. Dua's NIH Funded lab focuses on anticoagulation and biomarkers that are predictive of thrombosis and hemostasis in patients that have undergone revascularization.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Dr. Yana Etkin is board certified vascular surgeon and a Professor of Surgery at the Zucker School of Medicine at Hofstra/ Northwell. She serves as the Associate Chief of Vascular and Endovascular Surgery and a Program Director for the Vascular Surgery Fellowship and Residency programs.

Dr. Etkin received her medical degree from the Downstate Medical Center. She completed a residency in General Surgery at Montefiore Medical Center and a fellowship in Vascular Surgery at the Hospital of the University of Pennsylvania.

Dr. Etkin is a passionate educator who mentored and trained numerous medical students, residents, and fellows. She is an active member of numerous committees in local, regional and national societies with current and past leadership roles. In 2023, she has been elected as one of the directors for the Vascular Surgery Board of the American Board of Surgery.

She maintains busy clinical practice with special expertise in aortic surgery, venous pathology, critical limb ischemia, and dialysis access. Dr. Etkin also runs an active clinical research program focused on novel vascular surgical techniques and patient outcomes. She has authored over 50 peer-reviewed articles and several book chapters. She is an Associate Editor for Annals of Vascular Surgery Brief Reports and Innovations journal and is on the editorial board of several other medical journals. She has been an invited speaker and has led workshops/courses at more than 70 regional, national and international programs.

Sonya S. Noor, MD, FACS is an established Vascular Surgeon who started an independent practice BEVSA in 2007: 2 locations, in Buffalo, and in Williamsville NY. Dr. Noor has 21 years of experience. Her career in medicine began in 1992 after graduating from CMC moving to the United States, she completed a residency at SUNY in Syracuse, fellowship at the University at Buffalo and Arizona Heart Institute. Dr. Noor is a member of the AMA, the Western New York Vascular Society, and the EVS. She is the past president of the American College of Surgeons’ local chapter (ACS) and a member of the Society for Vascular Surgery (SVS).
Dr. Noor is dual board certified by the ABS is known internationally as aleading vascular surgeon,she is a Clinical Associate Professor, Department of Surgery, University of Buffalo, and is actively involved with teaching PA, medical, residents and fellows, since 2004.
She freqeuently serves as faculty on conferences such as CX, TED, OEIS, NCVH, VAM, EVS,and AMP, NHCC to name a few. She also serves as Medical Director of Endovascular Services at Buffalo General Medical Center and Gates Vascular Institute, Medical Director Access Care ,and Vascular Director at Jacobs Institute which is a unique medical technology Innovation center in Buffalo, NY. She recenlty added Advanced wound care services to HEr OBL access care which also offers HBOT.
Dr. Sonya Noor was awarded Top Vascular Surgeon in 2017, 2018, 2020 and 2021 and Women of Distinction 2018.and Buffalo Business first Entepreneours award 2023.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Dr. Sameh Sayfo is an interventional cardiologist and peripheral endovascular specialist based in Plano, Texas, affiliated with Baylor Scott & White Health. His practice focuses on complex coronary interventions, peripheral and carotid artery disease, endovascular aortic repair, and venous thromboembolic disease, with particular expertise in chronic venous occlusion, percutaneous transmural arterial bypass (PTAB), and minimally invasive carotid stenting. He serves as Director of the Pulmonary Embolism Response Team and Program Director of the Peripheral Endovascular Fellowship at Baylor Scott & White The Heart Hospital–Plano, Vice Chair of the PERT Consortium Education Committee, a contributor to the Vascular Disease Council at Society for Cardiovascular Angiography & Interventions, and Clinical Assistant Professor at Texas A&M University School of Medicine. Beyond his clinical and academic roles, Dr. Sayfo is a host for the BackTable Cardiology podcast, sharing insights on advanced cardiovascular techniques and innovative procedural outcomes with the global medical community

Dr. Wiechmann has been in private practice for 28 years with Vascular & Interventional Physicians in Gainesville, Florida, USA, with a particular interest in peripheral arterial disease & critical limb ischemia, abdominal aortic aneurysms, carotid intervention, and venous disease. He has been elected a Fellow in 4 different medical associations, including the Society of Interventional Radiology, the Society of Vascular Medicine, the American Heart Association, and the Outpatient Endovascular & Interventional Society (OEIS) and has served in many leadership roles in these societies. Dr. Wiechmann is a founding member of the Outpatient Endovascular & Interventional Society (OEIS), serves on the Board, and is past-President of OEIS. He has given over 270 invited lectures, has been principal investigator in numerous clinical trials in peripheral arterial intervention, carotid stenting, medical therapy for PAD, and stem cell therapy for critical limb ischemia, and is lead or co-author on over 35 peer-reviewed articles.

Dr. Khanjan “KJ” Nagarsheth is a vascular surgeon, Professor of Surgery, and Chief of the Division of Vascular Surgery at St. Louis University School of Medicine, where he also serves as System Director of Vascular Surgery for SSM Health in the St. Louis region. He is board certified in Vascular Surgery, General Surgery, and Surgical Critical Care. Dr. Nagarsheth completed his general surgery training at the University of Tennessee, fellowships in Surgical Critical Care and Acute Care Surgery at the R Adams Cowley Shock Trauma Center and University of Maryland, and vascular surgery fellowship training at Staten Island University Hospital/Northwell. He also earned an MBA in Entrepreneurship from the University of North Carolina at Chapel Hill.

Dr. Nagarsheth has developed nationally recognized programs in limb preservation, venous disease, vascular compression syndromes, pulmonary embolism care, and outpatient vascular interventions. His clinical and research interests focus on peripheral arterial disease, advanced venous disease, wound healing, thrombosis, and limb salvage innovation. He has authored more than 110 peer reviewed publications, multiple textbook chapters, and serves in numerous national leadership and editorial roles, including Associate Editor and Social Media Editor for the Journal of Vascular Surgery Cases and Innovative Techniques. He is an active mentor to medical students, residents, and fellows and is committed to advancing multidisciplinary vascular care, surgical education, and healthcare innovation.

Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016. She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she pioneers minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery and works in a multidisciplinary team to expand treatment options for patients with metastatic breast cancer through interventional oncology. She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s PAD program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her PAD screening trial examines the prevalence and disparities of PAD in at-risk cancer patients.

Dr. Pradeep K. Nair, an interventional cardiologist, is Vice-Chairman of New Cardiovascular Horizons Conference in New Orleans, LA. He joined the Cardiovascular Institute of the South (CIS) in 2015. A native of Somerset Pennsylvania, he graduated with University Honors from Carnegie Mellon University and earned his medical doctorate at Drexel University College of Medicine. He completed his residency in internal medicine and fellowships in cardiovascular disease and interventional cardiology at the University of Pittsburgh Medical Center Presbyterian Campus where he was recognized with several awards of distinction for his cardiovascular research. He went on to complete a year of an advanced endovascular interventional fellowship under the mentorship of Craig Walker at the CIS in Houma, LA.

Dr. Nair is licensed by the State Board of Medicine in Pennsylvania and Louisiana. He is board certified in internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology and echocardiography. He currently practices in Houma, Gray and Zachary, Louisiana where he specializes in peripheral arterial/venous disease and interventions. He is a fellow of the American College of Cardiology (ACC) and the Society of Cardiac Angiography and Interventions. He serves Horizon's International Peripheral Group, Board of OEIS, ACC Vascular Disease Section Leadership Council, and CLI Global Society Publication Committee. He has authored multiple peer-reviewed publications, book chapters, and presented and performed Live Endovascular Cases at several cardiovascular meetings. Having a keen clinical research interest of novel interventional devices and therapies, he is dedicated to supporting the advancement of our field.

Constantino S. Peña, M.D., serves as the Section Head of interventional radiology. He is the medical director of vascular imaging at Baptist Health Miami Cardiac & Vascular Institute.
Dr. Peña earned his bachelor’s and master’s degrees from Stanford University, and his medical degree from Yale University School of Medicine. He completed his residency in diagnostic radiology and a vascular and interventional fellowship in Massachusetts General Hospital in Boston, Massachusetts.
Dr. Peña is a clinical associate professor of radiology at Florida International University Herbert Wertheim College of Medicine. He has presented in numerous national and international meetings as well as participated in multiple clinical trials.
He has served for many professional organizations. He serves as the chair for the Cardiovascular Radiology & Intervention Council of the American Heart Association. He presently serves on the executive council of the Society of Interventional Radiology and was a past Annual Meeting Chair. He has served on several committee on the American Board of radiology and is a Board examiner. He also served on the Radiology Info Committee of the American College of Radiology and Radiological Society of North America and the Society of Interventional Radiology Oncology Service Line.
Dr. Peña is a fellow of the Society of Interventional Radiology, American Heart Association and the Society of Cardiovascular Computed Tomography (CT). He is also a member of the Radiological Society of North America, American College of Radiology, Society of Cardiovascular CT, Iberoamerican Society of Interventional Radiology and the North American Society for Cardiac Imaging.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Dr. Mike Watts attended the University of Buffalo for his medical training, earning his MD in 2006, completed surgical internship and radiology residency at the Cleveland Clinic in 2011 and his fellowship at the University of Pennsylvania in 2012. He was the fellowship director for interventional radiology at the University of Pennsylvania and the director of interventional radiology at the Philadelphia VA until 2016. Since then he has been committed to limb preservation, treating CLI on a full-time basis in an outpatient setting. He currently practices at the Vascular Institute of Atlantic Medical Imaging.

Dr. Winscott is Professor of Medicine and Surgery at the University of Mississippi Medical Center, with a dual appointment in the divisions of interventional cardiology and vascular surgery. He serves as the director of the adult cardiac catheterization laboratory and is the program director for both the interventional cardiology and the endovascular portion of the vascular surgery fellowship programs. He specializes in critical limb ischemia, limb salvage, CTO, alternative access, directional atherectomy, and anti-restenotic therapy. He serves as the vascular director for 5 wound care centers throughout the state of Mississippi.

Dr. John A. Phillips, MD is a cardiology and peripheral vascular interventionalist in Columbus, Ohio. He is affiliated with OhioHealth, Riverside Methodist Hospital and has been in practice there for 15 years. Dr. Phillips is the medical director for endovascular medicine and the clinical operations council chief for the heart and vascular service line at Riverside Methodist.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Born and raised in the Western Suburbs of Chicago. I have completed all of my educational and medical training in Chicago. I am a proud father of two young children. Currently I am dedicated to my podiatric practice and serve as the Associate Chief Medical Officer of our nationwide practice.

Mary Costantino MD, FSIR is a Interventional Radiologist in Portland, Oregon. She is the Owner/Operator at Advanced Vascular Centers, Portland and co-owner of Advanced Vascular Centers, Eugene. She has been in the outpatient arena since 2011. Her practice is focused on llimb salvage, uterine fibroids and venous disease.

Dr. Yana Etkin is board certified vascular surgeon and a Professor of Surgery at the Zucker School of Medicine at Hofstra/ Northwell. She serves as the Associate Chief of Vascular and Endovascular Surgery and a Program Director for the Vascular Surgery Fellowship and Residency programs.

Dr. Etkin received her medical degree from the Downstate Medical Center. She completed a residency in General Surgery at Montefiore Medical Center and a fellowship in Vascular Surgery at the Hospital of the University of Pennsylvania.

Dr. Etkin is a passionate educator who mentored and trained numerous medical students, residents, and fellows. She is an active member of numerous committees in local, regional and national societies with current and past leadership roles. In 2023, she has been elected as one of the directors for the Vascular Surgery Board of the American Board of Surgery.

She maintains busy clinical practice with special expertise in aortic surgery, venous pathology, critical limb ischemia, and dialysis access. Dr. Etkin also runs an active clinical research program focused on novel vascular surgical techniques and patient outcomes. She has authored over 50 peer-reviewed articles and several book chapters. She is an Associate Editor for Annals of Vascular Surgery Brief Reports and Innovations journal and is on the editorial board of several other medical journals. She has been an invited speaker and has led workshops/courses at more than 70 regional, national and international programs.

Dr Kum received his medical degree from the National University of Singapore in 2000 and
subsequently embarked on his surgical training with the Royal College of Surgeons,
obtaining his Master of Medicine and Fellowship in 2007.
In 2009, he completed his Postgraduate Fellowship in Vascular and Endovascular Surgery at
the Prince of Wales Hospital, Sydney as well as at the Department of Angiology, Heart
Centre Leipzig. In 2012, he completed a second Fellowship on Advanced Techniques in
Diabetic Limb Salvage and Wound Care Techniques in Milan.
Since 2015, Dr Kum has been the Director of Vascular Surgery at Department of Surgery,
Changi General Hospital Singapore and he was subsequently appointed as a Visiting
Consultant in 2019. He currently maintains his practice at Mount Elizabeth Novena
Hospital, Singapore and is currently the CMO of M & L Healthcare. Dr Kum is the past President of the
Society for Vascular and Endovascular Surgeons of Singapore (SVESS) and is part of the organizing committee of
Critical Issues in Endovascular Therapy, a regional meeting organized by the society.
Dr Kum has a keen interest in clinical research revolving around Diabetic Limb Salvage. He is
one of the pioneers in Percutaneous Deep Arterialization for no-option Critical Limb
Ischemia for which he has authored or co-authored numerous papers. He is the PI or co-PI
for several industry or physician led studies. He is also a keen innovator who is currently
working on several disruptive technologies.

Dr. Zola N’Dandu earned his medical degree from Eastern Virginia Medical School and completed training in Internal Medicine, Cardiology, and Interventional Cardiology at Ochsner Health, including advanced specialization in Peripheral Vascular Disease. He previously served as Section Head at Ochsner Medical Center–Kenner, where he developed a reputable program in Chronic Limb-Threatening Ischemia (CLTI). He currently practices at the Heart and Vascular Institute at Ascension Sacred Heart in Pensacola, Florida.

Dr. N’Dandu’s work centers on limb preservation through a multidisciplinary, collaborative approach to peripheral arterial disease (PAD). His clinical and academic interests include advanced infrapopliteal and inframalleolar interventions, as well as deep venous arterialization (DVA) for patients with limited options. He is actively engaged in research, innovation, clinical trials, and publication, and is dedicated to teaching residents and fellows. He also advocates for patient and community education to improve awareness, access, and outcomes in PAD care.

Jill Sommerset, RVT, FSVU, is a vascular technologist with 25 years of experience in advanced vascular ultrasound and limb preservation. Currently, she is the director of ultrasound at Advanced Vascular Centers and HOPE Vascular & Podiatry. She is also the director of Clinical Education and Training at Aveera Medical. She is known for developing Pedal Acceleration Time (PAT). Jill is also an international speaker recognized for her contributions to vascular ultrasound and improving patient outcomes.

Professor Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospital where he is director of surgery, anaesthetics and perioperative services for the South Eastern Sydney Local Health District. He is also director of the Prince of Wales operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice specialises in the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for which he is internationally renowned.

He has a strong academic interest in novel stent and anastomotic technologies, the investigation of intimal hyperplasia, and cellular mechanisms, and has the first-in-man experience with the Absorb bioresorbable stent technology applied below-the-knee. In 2015, he completed his PhD and in 2020 he completed a Masters in Clinical Epidemiology focussing on clinical trial design and biostatistics at the University of Sydney.

He is a Professor at the University of New South Wales where he teaches regularly. He is founder and course director of the New South Wales Vascular meeting and the VERVE symposium, the largest annual endovascular summit in Australasia.

He is a member of numerous learned societies, has published more than 130 peer reviewed manuscripts, five book chapters, is an invited reviewer for multiple leading journal in the field of vascular medicine, intervention and science, is on the editorial board of several of those same journals. He has been invited to speak both nationally and internationally on more than 300 individual occasions.

Dr. Wiechmann has been in private practice for 28 years with Vascular & Interventional Physicians in Gainesville, Florida, USA, with a particular interest in peripheral arterial disease & critical limb ischemia, abdominal aortic aneurysms, carotid intervention, and venous disease. He has been elected a Fellow in 4 different medical associations, including the Society of Interventional Radiology, the Society of Vascular Medicine, the American Heart Association, and the Outpatient Endovascular & Interventional Society (OEIS) and has served in many leadership roles in these societies. Dr. Wiechmann is a founding member of the Outpatient Endovascular & Interventional Society (OEIS), serves on the Board, and is past-President of OEIS. He has given over 270 invited lectures, has been principal investigator in numerous clinical trials in peripheral arterial intervention, carotid stenting, medical therapy for PAD, and stem cell therapy for critical limb ischemia, and is lead or co-author on over 35 peer-reviewed articles.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.